Last reviewed: June 2, 2026

Last updated: June 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Semaglutide dosing for weight loss begins at 0.25 mg weekly, titrating upward every 4 weeks to a typical maintenance range of 2.0–2.4 mg weekly. Starting low allows your body to adjust while minimizing nausea and other gastrointestinal effects—a key reason why dose escalation schedules exist in clinical practice.

The right starting dose and escalation path is not one-size-fits-all. Your age, BMI, kidney function, concurrent medications, and individual metabolic factors all influence how your provider will approach treatment. PlexusDx supports this personalized decision-making by offering genetic predisposition insights and transparent, flat-rate pricing so cost does not drive dosing decisions.

How Semaglutide Dosing Schedules Work in Clinical Practice

Standard semaglutide dosing follows a four-week titration protocol. You start at 0.25 mg, then increase to 0.5 mg in week 5, 1.0 mg in week 9, 1.7 mg in week 13, and potentially 2.4 mg in week 17. This gradual approach mirrors clinical trials and allows your GLP-1 receptor system to adapt while tolerability signals emerge.

Not every patient reaches 2.4 mg. Some see meaningful weight loss and metabolic benefits at 1.0 or 1.7 mg and choose to maintain there. Others tolerate higher doses better. Your provider may slow the escalation, pause at a maintenance dose, or adjust based on side effects, response metrics, and your treatment goals.

Clinical Factors That Influence Your Starting Dose and Escalation Timeline

Several evidence-based factors guide your provider's dosing recommendation. These include baseline BMI, age, kidney function, liver health, concurrent GLP-1 use, diabetes status, cardiovascular history, and recent medication changes. Labs and health history create a clinical picture that informs whether standard titration is appropriate or if modifications are warranted.

Clinical Factor Impact on Dosing Strategy
BMI ≥35 with metabolic syndrome May support standard or faster titration to reach maintenance dose; higher baseline metabolic dysfunction can benefit from effective GLP-1 dosing
Age 65+ or kidney function (eGFR 30–59) May warrant slower escalation or dose adjustment; renal impairment alters drug clearance and tolerability thresholds
History of gastroparesis or severe IBS May require extended titration intervals or lower maintenance target; GLP-1 slows gastric emptying and can worsen motility issues
Concurrent diabetes medications or SGLT2 inhibitors Risk of hypoglycemia or dehydration; dose coordination with provider essential to optimize benefit and minimize adverse events
Cardiovascular disease or heart failure Semaglutide has cardioprotective data; standard dosing supported by evidence, but close monitoring of weight loss speed and fluid status recommended

Biomarkers and Genetic Predispositions That May Inform Your Dosing Conversation

Emerging research suggests that genetic variants in GLP-1 receptor pathways, as well as baseline metabolic and inflammatory biomarkers, may provide context for how individuals respond to semaglutide. The Precision Peptide Genetic Test identifies predispositions in key peptide pathways—including GLP1R, GIPR, FTO, and MC4R variants—that may help providers personalize your treatment approach.

These genetic predispositions should not be interpreted as guarantees of response or intolerance. Instead, they can support a more informed conversation about which dose escalation strategy, monitoring intervals, and endpoint targets make sense for your unique biology. Combined with your clinical history, labs, and tolerability signals, genetic context contributes to precision dosing.

Safety Considerations and Who Should Start Semaglutide

Semaglutide is appropriate for adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related conditions. Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy, and severe kidney or liver disease. A qualified provider must review your full medical history before starting.

Common side effects during titration include nausea, vomiting, constipation, and decreased appetite—most mild to moderate and transient. Serious but rare risks include pancreatitis, gallbladder complications, and retinal changes in diabetes. Your provider should monitor you regularly, especially during the first 12 weeks of treatment and whenever the dose increases.

How PlexusDx Flat-Rate Pricing Supports Personalized Dosing Without Cost Pressure

A critical but often overlooked factor in dosing decisions is cost. Many patients stay on sub-therapeutic doses because they cannot afford higher ones. PlexusDx compounded semaglutide injection starts at $149/month and uses flat-rate pricing across three commitment tiers—your dose may go up, but your price will not. This removes financial barriers from clinical dosing decisions.

Whether your provider determines that your optimal maintenance dose is 1.0 mg or 2.4 mg, your monthly cost remains the same. PlexusDx also offers oral compounded semaglutide starting at $249/month, allowing you and your provider to focus on what works for your health, not what you can afford.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test reveals predispositions in GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants. These genetic markers may help provide context for your individual response patterns to semaglutide, informing whether faster titration, longer dose spacing, or earlier maintenance targeting might suit your biology—conversations best guided by your healthcare provider.

The genetic test does not predict exact semaglutide response or guarantee outcomes. Rather, it identifies predispositions in peptide pathways that can be interpreted with your clinical history, labs, and tolerability experience to build a more nuanced picture. This personalized context supports evidence-based dosing decisions tailored to your unique metabolic profile.

When combined with biomarker data (BMI, lipids, inflammation markers, kidney function) and your provider's clinical judgment, genetic predisposition insights can help you and your healthcare team design a starting dose, escalation timeline, and maintenance target that aligns with your health goals and tolerability threshold—maximizing efficacy while minimizing unnecessary side effects.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $279/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves